Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055

Reactive Oxygen Species and the Central Nervous System

Halliwell, B. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10990.x · Cited by 2,947

El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis

Brooks, B. R. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90191-0 · Cited by 2,171

Unified Huntington's disease rating scale: Reliability and consistency

Kremer, H. P. H. (1996) · Movement Disorders · doi:10.1002/mds.870110204 · Cited by 2,155

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471

The measurement and mechanism of lipid peroxidation in biological systems

Gutteridge, J. M. C., & Halliwell, B. B. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90206-q · Cited by 1,297

Alterations in mRNA expression of BACE1, cathepsin B, and glutaminyl cyclase in mice ischemic brain

Ye, J., Pi, R., Mao, X., Chen, X., Qin, J., Xu, S., & Liu, P. (2009) · Neuroreport · doi:10.1097/wnr.0b013e328332024a · Cited by 20

An Unrecognized Fundamental Relationship between Neurotransmitters: Glutamate Protects against Catecholamine Oxidation

Wang, W., Wu, X., Yang, C. S., & Zhang, J. (2021) · Antioxidants · doi:10.3390/antiox10101564 · Cited by 23

DNA Double-Strand Breaks Induced in Human Cells by Twelve Metallic Species: Quantitative Inter-Comparisons and Influence of the ATM Protein

Viau, M., Sonzogni, L., Ferlazzo, M. L., Berthel, É., Pereira, S., Bodgi, L., Granzotto, A., Devic, C., Fervers, B., Charlet, L., et al. (2021) · Biomolecules · doi:10.3390/biom11101462 · Cited by 25

The extraordinary resistance to UV radiations of a manganese superoxide dismutase of Deinococcus radiodurans offers promising potentialities in skin care applications

Palmieri, G., Arciello, S., Bimonte, M., Carola, A., Tito, A., Gogliettino, M., Cocca, E., Fusco, C., Balestrieri, M., Colucci, M. G., et al. (2019) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.07.002 · Cited by 19

Quantitative imaging of Cu, Fe, Mn and Zn in the L-DOPA-treated unilateral 6-hydroxydopamine Parkinson's disease mouse model by LA-ICP-MS

Sussulini, A., Matusch, A., Klietz, M., Bauer, A., Depboylu, C., & Becker, J. S. (2012) · Biomedical Spectroscopy and Imaging · doi:10.3233/bsi-2012-0011 · Cited by 17

ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of Parkinsonism

Beauchamp, L. C., Liu, X. M., Vella, L. J., Adlard, P. A., Bush, A. I., Finkelstein, D. I., & Barnham, K. J. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01300-0 · Cited by 15

Sub-Chronic Copper Pretreatment Reduces Oxidative Damage in an Experimental Huntington’s Disease Model

Martínez‐Lazcano, J. C., Montes, S., Sánchez-Mendoza, A., Rodríguez‐Páez, L., Pérez‐Neri, I., Boll, M., Campos-Arroyo, H. D., Rı́os, C., & Pérez‐Severiano, F. (2014) · Biological Trace Element Research · doi:10.1007/s12011-014-0127-0 · Cited by 15

Adaptation and Sensitization to Proteotoxic Stress

Leak, R. K. (2013) · Dose-Response · doi:10.2203/dose-response.13-016.leak · Cited by 14

Non-Ceruloplasmin Copper as a Stratification Biomarker of Alzheimer’s Disease Patients: How to Measure and Use It

Squitti, R., Ventriglia, M., Granzotto, A., Sensi, S. L., & Rongioletti, M. C. A. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666211022085755 · Cited by 14

Silicic Acid and Beer Consumption Reverses the Metal Imbalance and the Prooxidant Status Induced by Aluminum Nitrate in Mouse Brain

González‐Muñoz, M. J., Garcimartán, A., Meseguer, I., Mateos-Vega, C. J., Orellana, J. M., Peña‐Fernández, A., Benedı́, J., & Sánchez-Muniz, F. J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160972 · Cited by 14

Mangosteen Pericarp Extract Supplementation Boosts Antioxidant Status via Rebuilding Gut Microbiota to Attenuate Motor Deficit in 6-OHDA-Induced Parkinson’s Disease

Nurrahma, B. A., Yeh, T., Hsieh, R., Tsao, S., Chen, C., Lee, Y.-P., Pan, C., & Huang, H. (2022) · Antioxidants · doi:10.3390/antiox11122396 · Cited by 15

Copper Status Abnormalities and How to Measure Them in Neurodegenerative Disorders

Siotto, M., Bucossi, S., & Squitti, R. (2010) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488910793362395 · Cited by 13

La citotoxicidad del líquido cefalorraquídeo en la esclerosis lateral amiotrófica

Matías‐Guiu, J., Galán, L., García-Ramos, R., Barcia, J. A., & Guerrero, A. (2010) · Neurología · doi:10.1016/j.nrl.2010.01.006 · Cited by 12

Acid–Base Properties of the (1-4,18-36) Fragments of Neuropeptide K and their Mono- and Polynuclear Copper(II) Complexes Products of Metal-Catalyzed Oxidation

Błaszak, M., Jankowska, E., & Kowalik‐Jankowska, T. (2012) · Inorganic Chemistry · doi:10.1021/ic301476p · Cited by 12

Cerebrospinal fluid oxidative stress markers in Alzheimer's disease

Sakakibara, R., & Kawai, T. (2020) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12413 · Cited by 12

Molecular Features of Parkinson's Disease in Patient‐Derived Midbrain Dopaminergic Neurons

Ren, Y., Jiang, H., Pu, J., Li, L., Wu, J., Yan, Y., Zhao, G., Guttuso, T. J., Zhang, B., & Feng, J. (2021) · Movement Disorders · doi:10.1002/mds.28786 · Cited by 12

Heavy Metals and Multiple Sclerosis in Sardinian Population (Italy)

Madeddu, R., Forte, G., Bocca, B., Tolu, P., Sotgiu, M. A., Sotgiu, G., Marchal, J. A., Sotgiu, S., & Montella, A. (2011) · Analytical Letters · doi:10.1080/00032719.2010.520396 · Cited by 11

Trans Fatty Acids Enhanced Beta-Amyloid Induced Oxidative Stress in Nerve Growth Factor Differentiated PC12 Cells

Tsai, S.-J., Liu, W., & Yin, M. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0673-1 · Cited by 11

Monoamine Oxidase Inhibitors in Toxic Models of Parkinsonism

Бунеева, О. А., & Medvedev, A. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031248 · Cited by 11

Trichloroethylene exposure aggravates behavioral abnormalities in mice that are deficient in superoxide dismutase

Otsuki, N., Homma, T., Fujiwara, H., Kaneko, K., Hozumi, Y., Shichiri, M., Takashima, M., Ito, J., Konno, T., Kurahashi, T., et al. (2016) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2016.05.007 · Cited by 9

Unequivocal Biomarker for Parkinson’s Disease: A Hunt that Remains a Pester

Sarkar, A., Rawat, N., Sachan, N., & Singh, M. P. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00080-4 · Cited by 9

Quantitative susceptibility mapping reveals differences between subtypes of Lewy body dementia

Bhome, R., Thomas, G. E. C., Hannaway, N., Dobreva, I., Zarkali, A., Shmueli, K., Cole, J. H., & Weil, R. S. (2025) · Brain · doi:10.1093/brain/awaf325 · Cited by 8

Physical activity is linked to ceruloplasmin in the striatum of intact but not MPTP-treated primates

Leak, R. K., Garbett, K. A., Dettmer, A. M., Zhang, Z., Mirnics, K., & Cameron, J. L. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1488-3 · Cited by 8

Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms

Li, D.-N., Lian, T., Zhang, W.-J., Zhang, Y., Guo, P. F., Guan, H., Li, J., He, M., Zhang, W., Zhang, W., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.875059 · Cited by 7

Cerebrospinal fluid cytotoxicity in lateral amyotrophic sclerosis

Matías‐Guiu, J., Galán, L., García-Ramos, R., Barcia, J. A., & Guerrero, A. (2010) · Neurología (English Edition) · doi:10.1016/s2173-5808(10)70068-7 · Cited by 8

Coherent and Contradictory Facts, Feats and Fictions Associated with Metal Accumulation in Parkinson’s Disease: Epicenter or Outcome, Yet a Demigod Question

Rasheed, M. S. U., Tripathi, S., Mishra, S., & Singh, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0016-y · Cited by 5

Copper-mediated neurotoxicity and genetic vulnerability in the background of neurodegenerative diseases in C. elegans

Weishaupt, A.-K., Ruecker, L., Meiners, T., Schwerdtle, T., Ávila, D. S., Aschner, M., & Bornhorst, J. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae092 · Cited by 7

Combined EPR and Molecular Modeling Study of PPI Dendrimers Interacting with Copper Ions: Effect of Generation and Maltose Decoration

Furlan, S., Penna, G. L., Appelhans, D., Cangiotti, M., Ottaviani, M. F., & Danani, A. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp505420s · Cited by 7

Analysis of smoking and LPO in ALS

Anand, A., Gupta, P. K., Prabhakar, S. K., Sharma, S., & Thakur, K. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.04.004 · Cited by 7

Lipid peroxidation in the cerebrospinal fluid of patients with neurocysticercosis

Rodríguez, U., Rı́os, C., Corona, T., Talayero, B., Ostrosky‐Wegman, P., & Herrera, L. A. (2008) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2008.06.004 · Cited by 6

Ceruloplasmin-induced aggregation of P19 neurons involves a serine protease activity and is accompanied by reelin cleavage

Ducharme, P., Maltais, D., Desroches, D., Mateescu, M., & Paquin, J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.039 · Cited by 6

Dyshomeostasis of Iron and Its Transporter Proteins in Cypermethrin-Induced Parkinson’s Disease

Sachan, N., Tiwari, N., Patel, D. K., Katiyar, D., Srikrishna, S., & Singh, M. P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03436-2 · Cited by 6

Generation of hydrogen peroxide-resistant murine neuroblastoma cells: a target discovery platform for novel neuroprotective genes

Maczurek, A. E., Wild, R., Laurenti, D., Steele, M. L., Ooi, L., & Münch, G. W. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-0995-z · Cited by 6

An Update on CSF Biomarkers of Parkinson’s Disease

LeWitt, P. A., Huber, B. R., & Zhang, J. (2012) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-5866-7_8 · Cited by 6

Skogholt’s disease—A tauopathy precipitated by iron and copper?

Aspli, K. T., Holmøy, T., Flaten, T. P., Whist, J. E., & Aaseth, J. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126915 · Cited by 5

Oxidative modification of human ceruloplasmin induced by a catechol neurotoxin, salsolinol

Kim, S.-S., Kang, J. Y., & Kang, J. H. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.1.103 · Cited by 5

Biomarkers of Alzheimer′s Disease: From Central Nervous System to Periphery?

Mossello, E., Ballini, E., Mello, A. M., Tarantini, F., Simoni, D., Baldasseroni, S., & Marchionni, N. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2011/342980 · Cited by 5

Copper in Brain and Neurodegeneration

Liddell, J. R., Bush, A. I., & White, A. R. (2004) · Encyclopedia of Inorganic and Bioinorganic Chemistry · doi:10.1002/9781119951438.eibc2143 · Cited by 5

Diagnostic validity of biomarkers in Parkinson’s Disease: systematic review and meta-analysis

da Costa, M. F. B. N. A., Reisdorfer, E., Kempfer, S. S., Manfrini, G. C., Porporatti, A. L., & Canto, G. D. L. (2018) · Revista Brasileira de Enfermagem · doi:10.1590/0034-7167-2017-0822 · Cited by 4

Correction: Neocortex and Allocortex Respond Differentially to Cellular Stress In Vitro and Aging In Vivo

Posimo, J. M., Titler, A. M., Choi, H. J. H., Unnithan, A. S., & Leak, R. K. (2013) · PLoS ONE · doi:10.1371/annotation/6e168e79-a961-4746-80f7-5626502197af · Cited by 5

Copper, Ceruloplasmin, Zinc, and Manganese Levels in Brain and Biological Fluids from Parkinson’s Disease Patients: Systematic Review and Meta-Analysis

Jiménez-Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., Martín-Gómez, M. Á., Salgado-Cámara, P., Cárcamo-Fonfría, A., Arroyo-Solera, M., & Agúndez, J. A. G. (2026) · Cells · doi:10.3390/cells15030288 · Cited by 4

Mini-review: Processed red meat intake and risk of neurodegenerative diseases

Chen, K.-Q., Cao, W.-J., Liu, Z., & Liu, R.-Z. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1663647 · Cited by 3

Oxidation of Iron under Physiologically Relevant Conditions in Biological Fluids from Healthy and Alzheimer’s Disease Subjects

Lam, L. Q., Wong, B. X. W., Frugier, T., Li, Q., Collins, S. J., Bush, A. I., Crack, P. J., & Duce, J. A. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00411 · Cited by 3

Oxidative stress in farmed minks with self-biting behavior

Sun, D., Wang, J., & Xiurong, X. (2012) · Journal of Veterinary Behavior · doi:10.1016/j.jveb.2012.01.002 · Cited by 3

Blood and cerebrospinal fluid metallomics uncover mercury, chromium, and iron alterations in de novo Parkinson's disease

Dušek, P., Subramanian, R. G., Serranová, T., Šonka, K., Růžička, E., & Kuta, J. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251367303 · Cited by 2

Visualization of copper metabolic fluctuations across various stages of Parkinson’s disease by a near-infrared fluorescent sensor

Zang, S., Ke, J., Zheng, H., Liu, Q., Wang, B., Lan, M., & Song, X. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111822 · Cited by 2

Metals and Mitochondria in Neurodegeneration

Plascencia‐Villa, G., José–Yacamán, M., & Perry, G. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00015-4 · Cited by 2

Assessment of the role of gabapentin in patients with supratentorial tumours undergoing craniotomy under general anaesthesia: A double-blind randomised study

Soliman, R., & Zohry, G. (2017) · Journal of Neuroanaesthesiology and Critical Care · doi:10.4103/jnacc.jnacc_36_16 · Cited by 2

Synthesis and bio-activities of bifunctional tetrahydrosalen Cu (II) chelators with potential efficacy in Alzheimer's disease therapy

Sun, B., & Jiang, H. (2024) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2024.112636 · Cited by 2

Manganese and Huntington Disease

Tidball, A. M., Bichell, T. J., & Bowman, A. B. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622383-00540 · Cited by 2

Addressing Cu2+ interference for accurate aptamer-based biomarker determinations of Alzheimer’s disease

Cheng, X., Liu, D., Jin, Y., Yang, M., & Xiang, J. (2021) · Analytical Sciences · doi:10.2116/analsci.21p257 · Cited by 2

Metal Biology Associated with Huntington’s Disease

Bichell, T. J., Halbesma, T. C., Tipps, K. G., & Bowman, A. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00013-0 · Cited by 2

Cerebrospinal fluid biomarkers for neurodegenerative disorders

Videira, R. M. A. S. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 2

Cuproptosis-related genes associated with mitochondrial dysfunction in Parkinson’s disease

Liu, T., Li, J., Zhang, J., & Wei, J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0327550 · Cited by 1

Dysregulation of arginase and arginine pathways in neurodegenerative diseases: Metabolic and cellular dysfunction and therapeutic implications

Nalepa, M., Skweres, A., & Węgrzynowicz, M. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.05.285 · Cited by 1

Ceruloplasmin and neurodegeneration: A link between copper dysregulation, iron imbalance, and neuronal damage

Deepika, D., Kumar, J., Ali, S. A., Namdeo, A. G., & Flora, S. J. S. (2026) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2026.127929 · Cited by 1

Estado de la investigación sobre la enfermedad de Parkinson en México: de 1988 a 2010

Villar-Velarde, A., Rodríguez‐Violante, M., Cruz-Santillán, K., & Cervantes‐Arriaga, A. (2013) · Archivos de Neurociencias · Cited by 1

Biomarkers of Oxidative Stress in Parkinson’s Disease

Fernández‐Espejo, E. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00423 · Cited by 1

CFS Biomarkers in Parkinson’s Disease

Parnetti, L., Castrioto, A., De, C., Chiasserini, D., Tambasco, N., Rossi, A., Balducci, C., Beccari, T., & Calabresi, P. (2011) · InTech eBooks · doi:10.5772/16666 · Cited by 1

CSF biological antioxidant potentials may differentiate neurodegenerative diseases—A preliminary report

Kawai, T., Sakakibara, R., & Bujo, H. (2017) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12179 · Cited by 1

Alzheimer’s disease, cerebral blood flow, and nitric oxide.

Toda, N., & Ayajiki, K. (2010) · Folia Pharmacologica Japonica · doi:10.1254/fpj.135.20

An Investigation into the Role of Iron, Copper, and Gender in a Transgenic Mouse Model of Alzheimer's Disease.

Groeber, C. M. (2013) · doi:10.13021/mars/5636

Assessment of the role of gabapentin in patients with supratentorial tumours undergoing craniotomy under general anaesthesia: A double-blind randomised study

Soliman, R., & Zohry, G. (2017) · Journal of Neuroanaesthesiology and Critical Care · doi:10.4103/jnacc-jnacc-36.16

Cerebrospinal fluid biomarkers of Parkinson's disease: an update

Nagao, K. J., & LeWitt, P. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815946-0.00021-1

CSF Biomarkers in Parkinson's disease

Parnetti, L., Castrioto, A., Carlo, C. D., Chiasserini, D., Tambasco, N., Rossi, A., Michiara, M., Beccari, T., & Calabresi, P. (2011)

Nitric oxide and psychiatric disease; focusing on major depression and dementia

Ikenouchi, A., & Yoshimura, R. (2020) · Kyushu Neuropsychiatry · doi:10.11642/kyushuneurop.66.2_42

The effect of compounds on copper homeostasis in plasmodium falciparum and neuroblastoma cells

van Vuuren, J., & Natasha, C. Y. I. (2020)

Parkinson's disease

(2011) · Elsevier eBooks · doi:10.1016/b978-0-7295-3908-1.10031-4

Dyshomeostasis of iron and its transporter proteins in cypermethrin-inducedParkinson’s diseasePreprint

Sachan, N., Tiwari, N., Patel, D. K., Katiyar, D., Srikrishna, S., & Singh, M. P. (2022) · Research Square · doi:10.21203/rs.3.rs-2375066/v1

Estudo metalômico e proteômico em amostras de soro de pacientes com transtorno bipolar e esquizofrenia e as associações com os tratamentos

Cruz, E. C. S. (2020) · doi:10.47749/t/unicamp.2020.1157812

Exploring and Targeting the Connection of Iron and Copper Homeostasis to Neurodegenerative Diseases

Liu, X., Jia, L., Wu, K., Chen, M., Sun, J., Yang, C., Xu, C., Sun, J., Wang, J., & Dai, L. (2026) · MedComm · doi:10.1002/mco2.70766

Astrocytes in Parkinson’s disease: Beyond support, toward therapy

Wu, S., Wang, W., Yang, L., Pan, S., Thomas, E. R., & Li, X. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115964

Metals in Huntington's Disease and Other Disorders

Thoker, Z. A., & Marwaha, L. (2026) · IGI Global eBooks · doi:10.4018/979-8-2600-1403-5.ch012

Time-course of oxidation of lipids in human cerebrospinal fluidin vitro

Arlt, S., Finckh, B., Beisiegel†, U., & Kontush, A. (2000) · Free Radical Research · doi:10.1080/10715760000300111 · Cited by 27

PROTEINS MODIFICATIONS FOSTERED BY THE PRO-OXIDANT ENVIRONMENT OF PARKINSON�S AND ALZHEIMER�S DISEASES CEREBROSPINAL FLUID: THE CERULOPLASMIN CASE

Barbariga, M. (2014) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/barbariga-marco_phd2014-01-21

Synphilin-1 is present in Lewy bodies in Parkinson's disease

Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C. A., & Takahashi, H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4 · Cited by 269

Systemic Oxidative Stress in Patients with Neurodegenerative Diseases

Repetto, M. G., & Boveris, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-45865-6_22 · Cited by 3

Novel biomarker for neurodegenerative diseases- motor neuron disease (MND), cerebellar ataxia (CA) and Parkinson's disease (PD)

Pandey, S., Singh, B., Yadav, S. K., & Mahdi, A. A. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.07.021 · Cited by 20